Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis.
Front Pharmacol. 2020 Dec 15;11:615972. doi: 10.3389/fphar.2020.615972. eCollection 2020.
Front Pharmacol. 2020.
PMID: 33384605
Free PMC article.
Review.